Table 1.
Study design and procedure overview at the two cohorts.
Fig 1.
(a) Fox Wearable Companion app main screen; (b) Fox Wearable Companion app activity graph; (c) Fox Wearable Companion app movement during sleep graph; (d) Fox Wearable Companion app symptom self-reports.
“Reprinted from [Intel and Michael J Fox Foundation] under a CC BY license, with permission from [INTEL®], original copyright [2017].
Table 2.
Demographic and disease related characteristics of participants.
Fig 2.
Distribution of compliance among all enrolled participants in the NL (n = 304-black) and NAM (n = 649-white) study cohorts.
Fig 3.
Attrition in compliance per day for NL (n = 291, black) and NAM participants (n = 514, gray) during the follow up period.
Fig 4.
Number of participants actively collecting sensor data at the NL (gray) and NAM (black) cohorts during and after the follow-up period (total initial n = 805).
Fig 5.
SUS scoring of the Fox Wearable Companion platform (smartwatch with smartphone app) as rated by participants.
Table 3.
Distribution of data-contributors’ characteristics and influence on compliance for the NL and NAM cohorts.